Lucy Cook

Learn about the 5 key stages of our UpperNose™ Development Platform. In our latest webinar, Richard Johnson discusses the importance of target product selection in formulation and clinical development. Watch now ➡ https://lnkd.in/ees4VxRB #CDMO #DrugDevelopment #Webinar

17

Join Matthew Hewitt's presentation, “Fast technology coupled with deliberate regulatory: How can the field adapt new guidance to meet therapeutic demand?” CAR-TCR Summit Series As the number of CGT market approvals accelerates, Matt will discuss challenges in manufacturing and address how working collaboratively with partners and regulators aids in tackling the pain points of therapeutic development and clinical trial design. Don't miss this insightful session on regulatory guidance. https://okt.to/KTZMwk #cartcr #cgtdevelopment #celltherapy

17

In our latest #PharmorphixFix post, Veranova’s Senior Scientist, Ruth Lunt, explains how our Pharmorphix team helped a customer resolve batch-to-batch API manufacturing inconsistency through solid form and particle size control. Find out below how the team undertook a range of studies, employing multiple techniques and analyses, to develop a solution that resulted in high product yields and facilitated particle size optimization. You can also visit our website to find out more about our solid form and particle engineering capabilities and discover how we can help you overcome API complexity: https://lnkd.in/ehMqRZHK

53

Great day out at the #dxneconf24 today. Learnt a lot about the current challenges in diagnostics and the fantastic work researchers are doing! If you look closely enough you'll even spot me in their video! (blink and you'll miss it!). #biofortuna #diagnostics #lyophilization

6

In Drug Development & Delivery's recent special feature report on outsourcing #formulation development and #manufacturing, Abzena's Head of Formulation, Dr Gary Watts, discusses our customer-centric approach that supports complex biologics and ADCs throughout their entire lifecycle. From #preformulation and generation of formulations for toxicology and first-in-human (FIH) trials through to clinical in-use studies, formulation optimization, robust­ness, and device interaction studies, we streamline and de-risk the development path for our customers. Gary shares, "Broadly speaking, Abzena applies two approaches to formulation studies: First-in-Clinic approach, which is a streamlined methodology focused on enabling the cus­tomer to obtain FIH results in the shortest time possible; and a Best-in-Clinic ap­proach, focused on providing a superior product format to the competitors, often applied after Phase 1." Click here to access the full report and learn more about our unique two-pronged approach: https://lnkd.in/gp88BJQF #CDMO #CRO #drugdevelopment #biologics #ADCs

32

In the most recent edition of CCLM: Understanding the limitations of your assay using EQA data with serum creatinine as an example By Rachel Marrington and Finlay MacKenzie This is an Open Access Article: https://lnkd.in/eGbDcmeX

3

NICE already recommended Genedrive as the point-of-care test of choice in its draft guidance before clopidogrel administration in the management of Ischemic Stroke (IS) and Transient Ischaemic Attack (TIA) patients. Really great achievement outperforming the laboratory test with respect to accuracy! #diagnostics #pharmacogenetics #PGx #pointofcare #POCT #stroke #nhs

6

1 Comment

Are you looking for support to establish and scale your #cell and #gene therapy manufacturing capability? ➡️ https://ow.ly/riaa50UhzPr Our expert team can support you to accelerate your #AdvancedTherapy manufacturing and supply chain needs ensuring they are robust and efficient, whilst meeting all regulatory requirements. Learn more about how we can support you ☝️ #CellTherapy #GeneTherapy #ManufacturingInnovation

5

In recognition of Mental Health Awareness Month (a cause I am personally passionate about) I found some tips on how colleagues can support each other to look after our mental health at work. * Check in with your colleagues on a regular basis and ask them how they are doing * Encourage your colleagues to take a proactive approach to looking after their wellbeing * Understand your role and responsibility in creating a mentally healthy culture * Work towards creating a positive motivational climate for colleagues where they can thrive and be nurtured * Encourage colleagues to talk openly about how they are feeling and what they are thinking * Be supportive of colleagues who might be struggling. Listen to them, be understanding and demonstrate warmth and empathy * Support each other to practice active coping skills (Ex: Going for a walk or engage in deep breathing) * Fight against the stigma attached to mental healthy by being aware of the signs and symptoms of common mental health problems * Encourage colleagues to look after their physical health by staying active throughout the working day * Support colleagues to become aware of external support (like a company EAP program)

67

Did you catch this session? 📣 A few weeks ago, Lauren Black explored how the Dimensions Biotech Solution can help you gain a complete picture of increasingly complex research fields and rapidly growing markets such as OMICS, NGS and Cell&Gene. 🧬 Missed it? You can catch up on demand! 👨‍💻 Follow the link: https://lnkd.in/dfEcjwH3 #Biotech #NGS #OMICS #CellandGene #BiotechMarket #BiotechResearch #LifeSciences

5

Struggling with clinical trial compliance? Benefit from an immediate understanding of the regulatory requirements for unapproved in vitro diagnostic tests, dose adjustments and other patient sample testing in pharma and biopharma trials around the globe with ARC360. Learn more from Darren Ross during an interview state-side. #IVD #ClinicalStudies #RegulatoryCompliance #IVDR #ARCRegulatory https://lnkd.in/eqwxaiVU

5

As most might know we support a lot of analytical instrument providers across Europe and we've just released our 2025 insights and trends blog for the Scientific Equipment industry. Please feel free to forward it to anyone who may find it valuable. 😉 https://lnkd.in/e2rWk_J6

2

The injectability of biologic drug products from prefilled syringes (PFS) is a key challenge in PFS development. Discover in this whitepaper how advanced predictive injectability models, powered by proprietary imaging technologies and rheology analysis, enable first-time-right PFS selection at earlier stages, accelerating your PFS journey to market. Get your copy today: https://lnkd.in/eJt9GQ7M

24

1 Comment

Rapid, detailed cell analysis technology soon ready to assess the difference it can make to process insights and timelines

11

This latest episode was inspired by the upcoming biosecurity regulations in the USA. I did some research on the topic to provide information regarding China, USA, UK and the EU. I hope you will find it interesting. #clinicalresearch #genomicdata #biosecurity

1

Congratulations to the Nanocomp team for Commercial Activity of the Year award received at the SSPC, SFI Research Centre for Pharmaceuticals Annual Symposium this week at the University of Limerick. Working with Sarah Hudson on stage 1 of this project was arduous and a drag…as you can see from our faces in the picture below 😃. I mean, you can’t fake that kind of “chemistry”! I loved working with Nanocomp team every day even though they spoke a foreign language to me. I had to learn a whole new field of science from scratch. In every step they patiently taught me the basics, answered my silly questions, and through it all these highly respected and established scientists were always curious and open about what I had to say from the commercial perspective. That is why after a year’s hiatus, I decided to join them again. When I was considering all the opportunities that came my way in the last few months, I prioritized team dynamic and intellectual challange over other factors. Let’s face it, life is not getting any longer. It’s good to know what you need to get you out of bed every day. (Plus I get to say “plasma” in serious sentences a couple of times a week and for a Trekkie that’s reason enough no?!) Nanocomp is a novel solid drug formulation technology that can potentially enable more therapies to reach the market with significant manufacturing efficiencies and a smaller gentler environmental footprint. Considering the number of therapeutic molecules in the pipeline that are poorly water soluble, this is a very worthwhile venture to explore. I’ll spend the next year finalizing the business plan. Congratulations to the Nanocomp team on this award that is a testament to your dedication and hard work on this project: professors kieran hodnett Peter Davern Åke Rasmuson and the young scientists who built up an impressive body of data to support our claims: Ajay Kumar, Promita Bhattacharjee, Marta Bergillos Ruiz and Peuli Ghosh. Many thanks for SSPC, SFI Research Centre for Pharmaceuticals for the award and for investing so much in the supportive environment that allows innovation to thrive. And of course many thanks to Enterprise Ireland for generously funding this project and enabling the Nanocomp team to come together and do more. Majella Maher our EI advisor and partner in crime, thank you for keeping us on the righteous path and enabling this project every step of the way. You should be in this picture. We will miss you dearly as we finish stage 2. #Chemistry! Here we go again (literally and figuratively). And Bravo Nanocomp. #SSPC15 #UL

150

7 Comments